Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age Macular Degeneration”

1,501 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,501 results

Not applicableStudy completedNCT07514559
What this trial is testing

Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases

Who this might be right for
Age Related Macular Degeneration (ARMD)Retinal Vein Occlusion (RVO)Diabetic Macular Edema (DME)
Hospital Hietzing 393
Testing effectiveness (Phase 2)Study completedNCT02515942
What this trial is testing

CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Alcon Research 114
Large-scale testing (Phase 3)Ended earlyNCT01944839
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 619
Not applicableStudy completedNCT00001733
What this trial is testing

Screening for Studies on Retinovascular Diseases

Who this might be right for
Diabetic RetinopathyMacular DegenerationPathologic Neovascularization+1 more
National Eye Institute (NEI) 2,000
Large-scale testing (Phase 3)Study completedNCT00000145
What this trial is testing

Age-Related Eye Disease Study (AREDS)

Who this might be right for
Macular DegenerationCataractLens Opacities
National Eye Institute (NEI) 4,757
Not applicableStudy completedNCT05135195
What this trial is testing

A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

Who this might be right for
Visual ImpairmentAge-Related Macular DegenerationDiabetic Retinopathy+1 more
NYU Langone Health 98
Not applicableUnknownNCT01608113
What this trial is testing

Long-term Follow-up of Subfoveal Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Vienna 70
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537
What this trial is testing

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 168
Testing effectiveness (Phase 2)Study completedNCT03211234
What this trial is testing

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 76
Large-scale testing (Phase 3)UnknownNCT03609307
What this trial is testing

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 40
Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing

Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036
Not applicableStudy completedNCT03092492
What this trial is testing

AMD Ryan Initiative Study (ARIS)

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 26
Post-approval studies (Phase 4)UnknownNCT01213667
What this trial is testing

Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD

Who this might be right for
Macular Degeneration
University of Cologne 110
Not applicableEnded earlyNCT01717937
What this trial is testing

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

Who this might be right for
Age-related Macular DegenerationDiabetic RetinopathyHypertensive Retinopathy+2 more
University of California, San Francisco 10
Not applicableStudy completedNCT03919019
What this trial is testing

Morpho-functional Changes After Oral Supplementation of Antioxidants and Anti-inflammatory Treatment in Age-Related Macular Degeneration.

Who this might be right for
Dry AMD
Fondazione G.B. Bietti, IRCCS 30
Not applicableUnknownNCT00380172
What this trial is testing

Long-Term Efficacy in AMD of Rheopheresis in North America

Who this might be right for
Macular Degeneration
OccuLogix 120
Not applicableStudy completedNCT02090751
What this trial is testing

Development of a Device to Measure Dark Adaptation

Who this might be right for
Macular DegenerationAge-Related Macular Degeneration
University of Manchester 40
Testing effectiveness (Phase 2)Ended earlyNCT01577381
What this trial is testing

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Maculopathy
Pfizer 10
Early research (Phase 1)UnknownNCT00767949
What this trial is testing

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Lpath, Inc. 15
Next Page